期刊文献+

2017版甲状腺影像报告和数据系统诊断甲状腺良恶性结节的价值 被引量:14

Value of 2017thyroid imaging reporting and data system in diagnosis of benign and malignant thyroid nodules
下载PDF
导出
摘要 目的探讨2017版美国放射学院甲状腺影像报告和数据系统(TI-RADS)在评估甲状腺良恶性结节中的价值。方法采用2017版TI-RADS分类诊断标准,回顾性分析1 039例患者共1 109个甲状腺结节的声像图特征;以粗针穿刺活检或手术病理学结果为金标准,评价2017版TI-RADS对不同类别结节的诊断效能。结果良性结节551个,恶性结节558个;良恶性结节的成分、回声类型、纵横比、边界、有无钙化差异均有统计学意义(P均<0.05)。TI-RADS 2~5类结节中,恶性率分别为0、5.45%(3/55)、22.29%(39/175)和58.84%(516/877),差异有统计学意义(P<0.001)。以TI-RADS分类≥4为标准,诊断甲状腺恶性结节的敏感度、特异度、准确率、阳性预测值和阴性预测值分别为99.46%(555/558)、9.80%(54/551)、54.91%(609/1 109)、52.76%(555/1 052)和94.74%(54/57)。结论根据2017版TI-RADS分类评估恶性甲状腺结节具有临床应用价值,但特异度较低,分类标准尚需进一步完善。 Objective To explore the value of 2017 thyroid imaging reporting and data system(TI-RADS)suggested by American College of Radiology in diagnosis of benign and malignant thyroid nodules.Methods According to 2017 TIRADS,the sonographic features of 1 109 pathologically diagnosed thyroid nodules in 1 039 patients were retrospectively analyzed.Taken coarse needle biopsy or surgical pathology as the gold standards,the diagnostic efficacy of 2017 TI-RADS for different types of nodules was analyzed.Results Of 1 109 nodules,551 were benign and 558 were malignant.The composition,echogenicity,aspect ratio,boundary and calcification were statistically different between benign and malignant nodules(all P<0.05).The probability of malignancy in nodules with a classification of TI-RADS 2,3,4 and 5 was 0,5.45%(3/55),22.29%(39/175)and 58.84%(516/877),respectively,which had statistical difference(P<0.001).When TI-RADS classification were larger than 4,the diagnostic sensitivity,specificity,accuracy,positive predictive value and negative predictive value was 99.46%(555/558),9.80%(54/551),54.91%(609/1 109),52.76%(555/1 052)and 94.74%(54/57),respectively.Conclusion 2017 TI-RADS classification is based on the morphology and maximum diameter management of thyroid nodules,demonstrating clinical application value in evaluating malignant nodules,but the specificity is low,therefore needing further improvement.
作者 梁振威 陈路增 王彬 张惠 邵玉红 孙秀明 陈铭 LIANG Zhenwei;CHEN Luzeng;WANG Bin;ZHANG Hui;SHAO Yuhong;SUN Xiuming;CHEN Ming(Department of Diagnostic Ultrasound,Peking University First Hospital,Beijing100034,China)
出处 《中国介入影像与治疗学》 北大核心 2019年第3期162-166,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 北京大学第一医院青年临床研究专项(2017CR05)
关键词 甲状腺结节 超声检查 甲状腺影像报告和数据系统 thyroid nodule ultrasonography thyroid imaging reporting and data system
  • 相关文献

参考文献2

二级参考文献53

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献401

同被引文献124

引证文献14

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部